Brighton, MA, United States of America

Adrien F Soret

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Cubist Pharmaceuticals, Incorporated. Active years: 2015.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Adrien F Soret

Introduction

Adrien F Soret is a notable inventor based in Brighton, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibiotic compounds. His work has led to advancements that benefit both the medical community and patients.

Latest Patents

Adrien F Soret holds a patent for "Cephalosporin compositions and methods of manufacture." This patent describes a method for synthesizing cephalosporin antibiotic compounds. The innovative process involves the conversion of a protected 7-amino group into a 7-carboxamide moiety in a single step. This method enhances the efficiency of producing essential antibiotics.

Career Highlights

Soret is currently employed at Cubist Pharmaceuticals, Incorporated, where he continues to work on groundbreaking pharmaceutical innovations. His expertise in antibiotic synthesis has positioned him as a valuable asset in the industry. With 1 patent to his name, he exemplifies the spirit of innovation that drives progress in healthcare.

Collaborations

Throughout his career, Adrien has collaborated with talented individuals such as Pradip M Pathare and Jan-Ji Lai. These partnerships have fostered an environment of creativity and shared knowledge, leading to advancements in pharmaceutical research.

Conclusion

Adrien F Soret's contributions to the field of pharmaceuticals, particularly through his patent on cephalosporin compositions, highlight his role as an innovator. His work at Cubist Pharmaceuticals and collaborations with esteemed colleagues further emphasize his impact on antibiotic development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…